Carlyle Group sells 4.3% in Indegene for ₹636 cr

New Delhi: Global investment firm Carlyle Group through its arm divested a 4.3% stake in healthcare tech firm Indegene for ₹636 crore through an open market transaction.

According to the bulk deal data available on the National Stock Exchange (NSE), CA Dawn Investments, an affiliate of US-based Carlyle, sold 1,02,63,785 shares amounting to a 4.3% stake in Indegene.

The shares were offloaded at an average price of ₹619.82 apiece, taking the transaction value to ₹636.17 crore.

After the latest transaction, Carlyle's holding in Indegene has come down to 10.22% from 14.52%.

Details of the buyers of Indegene's shares could not be ascertained on the NSE.

Shares of Indegene plunged 6.06% to close at ₹627 apiece on the NSE.

In two separate deals on the NSE and BSE, financial services company Capital Group on Tuesday trimmed its holding by selling a 2.24% stake in Medi Assist Healthcare Services for nearly ₹93 crore through open market transactions.

Capital through its arm SmallCap World Fund Inc sold a total of 15.75 lakh shares, or 2.24% stake in Medi Assist Healthcare Services on the NSE and BSE, as per the data.

The shares were disposed of at an average price of ₹588 apiece on both exchanges, taking the combined deal value to ₹92.65 crore.

After the stake sale, Capital Group through its arm SmallCap World Fund Inc's shareholding in Medi Assist Healthcare Services has declined to 0.7% from 2.93%. Details of the buyers of Medi Assist Healthcare Services could not be identified on the exchanges.

On Tuesday, shares of Medi Assist Healthcare Services rose 0.18% to close at ₹588.20 apiece on the BSE, while it settled 0.06% lower at ₹586.20 per piece on the NSE.